NCT07063537Recruiting
Feasibility, Accuracy, and Reproducibility of Virtual Reality Visual Field Testing in Patients With Glaucoma
Evaluation of the Accuracy and Reproducibility of Visual Field Testing Using a Virtual Reality Head-Mounted Device for Patients With Early, Moderate, and Advanced Glaucoma
Source: ClinicalTrials.gov · Last updated 14 Jul 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The goal of this clinical trial is to evaluate the feasibility of using virtual reality based visual field testing to monitor glaucoma in a clinical setting. This will be done through comparison of a virtual reality (VR) based device to the current gold standard Ziess Humphrey Field Analyzer (HFA). The main questions the study aims to answer are: * Can both devices produce similar results in terms of detecting visual field defects and progression? * Does the stage (early, moderate, advanced) of glaucoma impact results between the two devices? Participants will perform both a standard and a VR based visual field test at each visit, for a total of 5 visits.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- First submitted
- 20 Jun 2025
- Start date
- 14 Dec 2024
- Primary completion date
- Oct 2025
- Lead sponsor
- Nova Scotia Health Authority
- Diseases
- Glaucoma
- NCT number
- NCT07063537
What you commit to
- Study type: Interventional
- Planned participants: 60
- From 14 Dec 2024 to the primary completion date, Oct 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- previous intraocular surgery (excluding cataract surgery and minimally invasive glaucoma surgery)
Other illness
- seizure disorder
- cardiac pacemaker/other implantable device
- severe vertigo/balance disorder
Other
- diagnosis of secondary glaucoma or non-glaucomatous optic neuropathy
- significant media opacity
- pregnancy
Who the study is looking for
- \>18 years of age
- diagnosis of primary open-angle glaucoma
- ability to perform visual field testing
- capacity to provide informed consent to research protocol
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Eadie Technologies Inc Coordinator of this site? Confirm its status | Halifax | Canada | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.